Delivery Order SPE2DB22D2218-SPE2DB25FR2KX
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$48K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,839.70 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,746.70 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $18,322.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,956,492 units of the medication CAPLYTA 42 MG CAPSULE 30S, with a performance period extending through April 18, 2025. The contract is not set aside and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp, headquartered in Conshohocken,...
This federal contract award, valued at $6,226.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a medication, with an ultimate completion date of April 24, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,252.05 firm fixed-price delivery order contract is for the provision of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,173.63, is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is a delivery order valued at $25,563.63 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through March 19, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a $10,153.73 firm-fixed price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 4,566,078,136 units of the pharmaceutical product CAPLYTA 42 MG CAPSULE 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,472.32 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,526.77 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a medical product. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...